SwissTecLive: effectiveness and safety of dimethyl fumarate in the treatment of RRMS in the Swiss clinical practice setting

BACKGROUND: Delayed-released dimethyl fumarate (DMF) is an oral disease-modifying therapy (DMT) approved for treating patients with multiple sclerosis (MS). This post-marketing study aimed at collecting real-world data on the safety, effectiveness, and tolerability of DMF in patients with relapsing...

Descripción completa

Detalles Bibliográficos
Autores principales: Zecca, Chiara, Czaplinski, Adam, Henny, Christophe, Petrini, Liliane, Beeler, Andreas, Gobbi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772546/
https://www.ncbi.nlm.nih.gov/pubmed/33385094
http://dx.doi.org/10.1016/j.heliyon.2020.e05819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772546/
https://www.ncbi.nlm.nih.gov/pubmed/33385094
http://dx.doi.org/10.1016/j.heliyon.2020.e05819

Ejemplares similares